Literature DB >> 7284322

Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds.

F J Martin, W L Hubbell, D Papahadjopoulos.   

Abstract

An efficient method for covalently cross-linking 50K Fab' antibody fragments to the surface of lipid vesicles is reported. Coupling up to 600 microgram of Fab'/mumol of phospholipid (about 6000 Fab' molecules per 0.2-micrometer vesicle) is achieved via a disulfide interchange reaction between the thiol group exposed on each Fab' fragment and a pyridyldithio-derivative of phosphatidylethanolamine present in low concentration in the membranes of preformed large unilamellar vesicles. The coupling reaction is efficient, proceeds rapidly under mild conditions, and yields well-defined products. Each vesicle-linked Fab' fragment retains its original antigenic specificity and full capacity to bind antigen. We have used Fab' fragments, coupled to vesicles by this method, to achieve immunospecific targeting of liposomes to cells in vitro. Vesicles bearing antihuman erythrocyte Fab' fragments bind quantitatively to human erythrocytes (at multiplicities up to 5000 0.2-micrometer vesicles per cell) while essentially no binding is observed to sheep or ox red blood cells. Vesicle-cell binding is stable over a pH range from 6 to 8 and is virtually unaffected by the presence of human serum (50%). Cell-bound vesicles retain their aqueous contents and can be eluted intact from cells by treatment with reducing agents (dithiothreitol or mercaptoethanol) at alkaline pH.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284322     DOI: 10.1021/bi00517a043

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Two-dimensional recognition pattern of lipid-anchored Fab' fragments.

Authors:  M Egger; S P Heyn; H E Gaub
Journal:  Biophys J       Date:  1990-03       Impact factor: 4.033

2.  New method for site-specific modification of liposomes with proteins using sortase A-mediated transpeptidation.

Authors:  Xueqing Guo; Zhimeng Wu; Zhongwu Guo
Journal:  Bioconjug Chem       Date:  2012-03-08       Impact factor: 4.774

3.  Preparation of functional liposomes with peptide ligands and their binding to cell membranes.

Authors:  N Yagi; Y Ogawa; M Kodaka; T Okada; T Tomohiro; T Konakahara; H Okuno
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

Review 4.  Microinjection of somatic cells with micropipettes: comparison with other transfer techniques.

Authors:  J E Celis
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

Review 5.  Immunoglobulins as targeting agents for liposome encapsulated drugs.

Authors:  P A Toonen; D J Crommelin
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

6.  Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.

Authors:  G Gregoriadis
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

7.  Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.

Authors:  T D Heath; J A Montgomery; J R Piper; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

8.  The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma.

Authors:  Arun K Iyer; Yang Su; Jinjin Feng; Xiaoli Lan; Xiaodong Zhu; Yue Liu; Dongwei Gao; Youngho Seo; Henry F Vanbrocklin; V Courtney Broaddus; Bin Liu; Jiang He
Journal:  Biomaterials       Date:  2011-01-20       Impact factor: 12.479

9.  Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  J Nanoneurosci       Date:  2009-06-01

Review 10.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.